Pancreatic Carcinoma — Trials

Pancreatic Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,381 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 488
Recruiting: 282
Ph III recruiting: 29
Growth YoY: +31.5%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (201)

clinicaltrialsPublishedShowing 51–66 of 66 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03245541	Radiation Therapy in Combination With Durvalumab for People With Pancreatic Cancer	active not recruiting	Phase 1 / Phase 2	18	Memorial Sloan Kettering Cancer CenterOTHER	1	Oct 7, 2025	clinicaltrials
NCT05585320	A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors	active not recruiting	Phase 1 / Phase 2	209	Immuneering CorporationINDUSTRY	1	Sep 2, 2025	clinicaltrials